Tag: VIVA 17
IVC filter moratorium “not in the best interests of our patients”
Inferior vena cava (IVC) filters have been a highly controversial topic in the field of venous medicine due to the high rates of complications associated with...
One-year SENTRY trial data offer a “a new perspective” on IVC...
Twelve-month results from the SENTRY trial evaluating the Sentry bioconvertible inferior vena cava (IVC) filter (Novate) have shown a 0% rate of symptomatic pulmonary...